nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromocriptine—DRD4—conduct disorder	0.583	0.684	CbGaD
Bromocriptine—HTR2A—conduct disorder	0.269	0.316	CbGaD
Bromocriptine—HTR7—autonomic nervous system—conduct disorder	0.00385	0.234	CbGeAlD
Bromocriptine—HTR2A—autonomic nervous system—conduct disorder	0.0024	0.146	CbGeAlD
Bromocriptine—Methylergometrine—HTR2A—conduct disorder	0.00173	0.403	CrCbGaD
Bromocriptine—Methysergide—HTR2A—conduct disorder	0.00144	0.337	CrCbGaD
Bromocriptine—DRD4—brain—conduct disorder	0.00118	0.0718	CbGeAlD
Bromocriptine—Ergotamine—HTR2A—conduct disorder	0.00111	0.26	CrCbGaD
Bromocriptine—DRD3—brain—conduct disorder	0.000831	0.0505	CbGeAlD
Bromocriptine—HTR6—brain—conduct disorder	0.0008	0.0486	CbGeAlD
Bromocriptine—DRD5—brain—conduct disorder	0.000779	0.0473	CbGeAlD
Bromocriptine—ADRA1B—brain—conduct disorder	0.000639	0.0388	CbGeAlD
Bromocriptine—ADRA1D—brain—conduct disorder	0.000625	0.0379	CbGeAlD
Bromocriptine—DRD1—brain—conduct disorder	0.000595	0.0361	CbGeAlD
Bromocriptine—HTR1B—brain—conduct disorder	0.000482	0.0293	CbGeAlD
Bromocriptine—HTR1D—brain—conduct disorder	0.000467	0.0284	CbGeAlD
Bromocriptine—HTR2C—brain—conduct disorder	0.000462	0.0281	CbGeAlD
Bromocriptine—ADRB1—brain—conduct disorder	0.000454	0.0276	CbGeAlD
Bromocriptine—HTR2B—brain—conduct disorder	0.000434	0.0264	CbGeAlD
Bromocriptine—HTR1A—brain—conduct disorder	0.000389	0.0236	CbGeAlD
Bromocriptine—HTR7—brain—conduct disorder	0.000372	0.0226	CbGeAlD
Bromocriptine—ADRA1A—brain—conduct disorder	0.000359	0.0218	CbGeAlD
Bromocriptine—DRD2—brain—conduct disorder	0.000352	0.0214	CbGeAlD
Bromocriptine—ADRA2C—brain—conduct disorder	0.000342	0.0208	CbGeAlD
Bromocriptine—ADRA2A—brain—conduct disorder	0.000273	0.0166	CbGeAlD
Bromocriptine—HTR2A—brain—conduct disorder	0.000232	0.0141	CbGeAlD
Bromocriptine—ABCB1—brain—conduct disorder	0.000152	0.00923	CbGeAlD
Bromocriptine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	8.25e-05	0.000646	CbGpPWpGaD
Bromocriptine—DRD2—GPCR ligand binding—DRD4—conduct disorder	8.25e-05	0.000646	CbGpPWpGaD
Bromocriptine—HTR1D—GPCR ligand binding—HTR2A—conduct disorder	8.21e-05	0.000644	CbGpPWpGaD
Bromocriptine—HTR7—Circadian rythm related genes—EP300—conduct disorder	8.2e-05	0.000642	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—CGA—conduct disorder	8.2e-05	0.000642	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR downstream signaling—CGA—conduct disorder	8.19e-05	0.000642	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR ligand binding—DRD4—conduct disorder	8.11e-05	0.000636	CbGpPWpGaD
Bromocriptine—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	8.05e-05	0.000631	CbGpPWpGaD
Bromocriptine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.05e-05	0.000631	CbGpPWpGaD
Bromocriptine—HTR1B—GPCR ligand binding—HTR2A—conduct disorder	8.04e-05	0.00063	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—CGA—conduct disorder	8.02e-05	0.000628	CbGpPWpGaD
Bromocriptine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8e-05	0.000627	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	7.94e-05	0.000623	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR ligand binding—DRD4—conduct disorder	7.94e-05	0.000623	CbGpPWpGaD
Bromocriptine—DRD4—GPCR ligand binding—HTR2A—conduct disorder	7.91e-05	0.00062	CbGpPWpGaD
Bromocriptine—DRD4—Circadian rythm related genes—EP300—conduct disorder	7.85e-05	0.000615	CbGpPWpGaD
Bromocriptine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.79e-05	0.00061	CbGpPWpGaD
Bromocriptine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.66e-05	0.0006	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—CGA—conduct disorder	7.56e-05	0.000592	CbGpPWpGaD
Bromocriptine—HTR2B—GPCR ligand binding—HTR2A—conduct disorder	7.56e-05	0.000592	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—CGA—conduct disorder	7.45e-05	0.000584	CbGpPWpGaD
Bromocriptine—HTR1A—SIDS Susceptibility Pathways—EP300—conduct disorder	7.44e-05	0.000583	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—CGA—conduct disorder	7.43e-05	0.000583	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	7.38e-05	0.000578	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR ligand binding—DRD4—conduct disorder	7.38e-05	0.000578	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—CGA—conduct disorder	7.28e-05	0.00057	CbGpPWpGaD
Bromocriptine—HTR6—GPCR downstream signaling—DRD4—conduct disorder	7.17e-05	0.000562	CbGpPWpGaD
Bromocriptine—HTR7—GPCR downstream signaling—DRD4—conduct disorder	7.16e-05	0.000561	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—WASF1—conduct disorder	7.13e-05	0.000559	CbGpPWpGaD
Bromocriptine—DRD1—GPCR ligand binding—HTR2A—conduct disorder	7.13e-05	0.000558	CbGpPWpGaD
Bromocriptine—HTR1D—GPCR downstream signaling—DRD4—conduct disorder	7.11e-05	0.000558	CbGpPWpGaD
Bromocriptine—DRD1—Circadian rythm related genes—EP300—conduct disorder	7.07e-05	0.000554	CbGpPWpGaD
Bromocriptine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.06e-05	0.000554	CbGpPWpGaD
Bromocriptine—ADRA1D—GPCR ligand binding—HTR2A—conduct disorder	7.03e-05	0.000551	CbGpPWpGaD
Bromocriptine—DRD3—GPCR ligand binding—HTR2A—conduct disorder	7.03e-05	0.000551	CbGpPWpGaD
Bromocriptine—DRD3—Circadian rythm related genes—EP300—conduct disorder	6.97e-05	0.000546	CbGpPWpGaD
Bromocriptine—HTR1B—GPCR downstream signaling—DRD4—conduct disorder	6.97e-05	0.000546	CbGpPWpGaD
Bromocriptine—CYP1A2—Biological oxidations—COMT—conduct disorder	6.96e-05	0.000546	CbGpPWpGaD
Bromocriptine—CYP1A2—Biological oxidations—MAOA—conduct disorder	6.91e-05	0.000542	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—CGA—conduct disorder	6.87e-05	0.000538	CbGpPWpGaD
Bromocriptine—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	6.87e-05	0.000538	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—CGA—conduct disorder	6.86e-05	0.000538	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—CGA—conduct disorder	6.82e-05	0.000534	CbGpPWpGaD
Bromocriptine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	6.81e-05	0.000533	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—CGA—conduct disorder	6.76e-05	0.00053	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—CGA—conduct disorder	6.67e-05	0.000523	CbGpPWpGaD
Bromocriptine—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	6.62e-05	0.000518	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—CGA—conduct disorder	6.57e-05	0.000515	CbGpPWpGaD
Bromocriptine—HTR2B—GPCR downstream signaling—DRD4—conduct disorder	6.54e-05	0.000513	CbGpPWpGaD
Bromocriptine—HTR6—Signaling by GPCR—DRD4—conduct disorder	6.51e-05	0.00051	CbGpPWpGaD
Bromocriptine—HTR7—Signaling by GPCR—DRD4—conduct disorder	6.5e-05	0.00051	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling by GPCR—DRD4—conduct disorder	6.46e-05	0.000506	CbGpPWpGaD
Bromocriptine—HTR2A—SIDS Susceptibility Pathways—EP300—conduct disorder	6.43e-05	0.000504	CbGpPWpGaD
Bromocriptine—ADRB1—GPCR ligand binding—HTR2A—conduct disorder	6.41e-05	0.000502	CbGpPWpGaD
Bromocriptine—ADRA2B—GPCR ligand binding—HTR2A—conduct disorder	6.35e-05	0.000497	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling by GPCR—DRD4—conduct disorder	6.33e-05	0.000496	CbGpPWpGaD
Bromocriptine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	6.32e-05	0.000496	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—CGA—conduct disorder	6.27e-05	0.000491	CbGpPWpGaD
Bromocriptine—DRD1—GPCR downstream signaling—DRD4—conduct disorder	6.17e-05	0.000484	CbGpPWpGaD
Bromocriptine—HTR1A—GPCR ligand binding—HTR2A—conduct disorder	6.13e-05	0.00048	CbGpPWpGaD
Bromocriptine—HTR2C—GPCR ligand binding—HTR2A—conduct disorder	6.1e-05	0.000478	CbGpPWpGaD
Bromocriptine—ADRA1D—GPCR downstream signaling—DRD4—conduct disorder	6.09e-05	0.000477	CbGpPWpGaD
Bromocriptine—DRD3—GPCR downstream signaling—DRD4—conduct disorder	6.09e-05	0.000477	CbGpPWpGaD
Bromocriptine—DRD5—GPCR downstream signaling—HTR2A—conduct disorder	6.06e-05	0.000475	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling by GPCR—DRD4—conduct disorder	5.94e-05	0.000466	CbGpPWpGaD
Bromocriptine—ADRA2C—GPCR ligand binding—HTR2A—conduct disorder	5.93e-05	0.000465	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	5.92e-05	0.000464	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—CGA—conduct disorder	5.91e-05	0.000463	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—CGA—conduct disorder	5.88e-05	0.000461	CbGpPWpGaD
Bromocriptine—ADRA1B—GPCR ligand binding—HTR2A—conduct disorder	5.84e-05	0.000457	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—CGA—conduct disorder	5.83e-05	0.000457	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—CGA—conduct disorder	5.83e-05	0.000457	CbGpPWpGaD
Bromocriptine—DRD1—Signaling by GPCR—DRD4—conduct disorder	5.6e-05	0.000439	CbGpPWpGaD
Bromocriptine—ADRB1—GPCR downstream signaling—DRD4—conduct disorder	5.55e-05	0.000435	CbGpPWpGaD
Bromocriptine—DRD3—Signaling by GPCR—DRD4—conduct disorder	5.53e-05	0.000433	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling by GPCR—DRD4—conduct disorder	5.53e-05	0.000433	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—WASF1—conduct disorder	5.5e-05	0.000431	CbGpPWpGaD
Bromocriptine—DRD5—Signaling by GPCR—HTR2A—conduct disorder	5.5e-05	0.000431	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—WASF1—conduct disorder	5.5e-05	0.000431	CbGpPWpGaD
Bromocriptine—ADRA2B—GPCR downstream signaling—DRD4—conduct disorder	5.5e-05	0.000431	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—WASF1—conduct disorder	5.46e-05	0.000428	CbGpPWpGaD
Bromocriptine—DRD2—GPCR ligand binding—HTR2A—conduct disorder	5.38e-05	0.000422	CbGpPWpGaD
Bromocriptine—CYP3A4—Biological oxidations—COMT—conduct disorder	5.37e-05	0.000421	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—WASF1—conduct disorder	5.35e-05	0.000419	CbGpPWpGaD
Bromocriptine—CYP3A4—Biological oxidations—MAOA—conduct disorder	5.34e-05	0.000418	CbGpPWpGaD
Bromocriptine—DRD2—Circadian rythm related genes—EP300—conduct disorder	5.33e-05	0.000418	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—CGA—conduct disorder	5.31e-05	0.000416	CbGpPWpGaD
Bromocriptine—HTR1A—GPCR downstream signaling—DRD4—conduct disorder	5.31e-05	0.000416	CbGpPWpGaD
Bromocriptine—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	5.3e-05	0.000415	CbGpPWpGaD
Bromocriptine—HTR2C—GPCR downstream signaling—DRD4—conduct disorder	5.28e-05	0.000414	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—CGA—conduct disorder	5.27e-05	0.000413	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—WASF1—conduct disorder	5.26e-05	0.000412	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR ligand binding—HTR2A—conduct disorder	5.18e-05	0.000406	CbGpPWpGaD
Bromocriptine—ADRA2C—GPCR downstream signaling—DRD4—conduct disorder	5.14e-05	0.000402	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—CGA—conduct disorder	5.08e-05	0.000398	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—CGA—conduct disorder	5.06e-05	0.000396	CbGpPWpGaD
Bromocriptine—ADRA1B—GPCR downstream signaling—DRD4—conduct disorder	5.05e-05	0.000396	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—DRD4—conduct disorder	5.04e-05	0.000395	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—WASF1—conduct disorder	5.02e-05	0.000394	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—DRD4—conduct disorder	4.99e-05	0.000391	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—DRD4—conduct disorder	4.98e-05	0.00039	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—CGA—conduct disorder	4.92e-05	0.000385	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CGA—conduct disorder	4.84e-05	0.000379	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—DRD4—conduct disorder	4.82e-05	0.000378	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR ligand binding—HTR2A—conduct disorder	4.82e-05	0.000377	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—DRD4—conduct disorder	4.79e-05	0.000376	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—CGA—conduct disorder	4.78e-05	0.000374	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—WASF1—conduct disorder	4.74e-05	0.000371	CbGpPWpGaD
Bromocriptine—HTR6—GPCR downstream signaling—HTR2A—conduct disorder	4.68e-05	0.000367	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—WASF1—conduct disorder	4.67e-05	0.000366	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—WASF1—conduct disorder	4.67e-05	0.000366	CbGpPWpGaD
Bromocriptine—HTR7—GPCR downstream signaling—HTR2A—conduct disorder	4.67e-05	0.000366	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—DRD4—conduct disorder	4.66e-05	0.000365	CbGpPWpGaD
Bromocriptine—DRD2—GPCR downstream signaling—DRD4—conduct disorder	4.66e-05	0.000365	CbGpPWpGaD
Bromocriptine—HTR1D—GPCR downstream signaling—HTR2A—conduct disorder	4.64e-05	0.000364	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—DRD4—conduct disorder	4.59e-05	0.00036	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR downstream signaling—DRD4—conduct disorder	4.58e-05	0.000359	CbGpPWpGaD
Bromocriptine—HTR1B—GPCR downstream signaling—HTR2A—conduct disorder	4.55e-05	0.000356	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—DRD4—conduct disorder	4.49e-05	0.000352	CbGpPWpGaD
Bromocriptine—DRD4—GPCR downstream signaling—HTR2A—conduct disorder	4.47e-05	0.000351	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CGA—conduct disorder	4.46e-05	0.00035	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CGA—conduct disorder	4.39e-05	0.000344	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CGA—conduct disorder	4.3e-05	0.000337	CbGpPWpGaD
Bromocriptine—HTR2B—GPCR downstream signaling—HTR2A—conduct disorder	4.27e-05	0.000335	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—WASF1—conduct disorder	4.26e-05	0.000334	CbGpPWpGaD
Bromocriptine—HTR6—Signaling by GPCR—HTR2A—conduct disorder	4.25e-05	0.000333	CbGpPWpGaD
Bromocriptine—HTR7—Signaling by GPCR—HTR2A—conduct disorder	4.24e-05	0.000333	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—DRD4—conduct disorder	4.23e-05	0.000332	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—WASF1—conduct disorder	4.22e-05	0.000331	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling by GPCR—HTR2A—conduct disorder	4.22e-05	0.00033	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—DRD4—conduct disorder	4.17e-05	0.000327	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—DRD4—conduct disorder	4.16e-05	0.000326	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling by GPCR—HTR2A—conduct disorder	4.13e-05	0.000323	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—DRD4—conduct disorder	4.08e-05	0.000319	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—WASF1—conduct disorder	4.07e-05	0.000319	CbGpPWpGaD
Bromocriptine—DRD4—Signaling by GPCR—HTR2A—conduct disorder	4.06e-05	0.000318	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—WASF1—conduct disorder	4.05e-05	0.000318	CbGpPWpGaD
Bromocriptine—DRD1—GPCR downstream signaling—HTR2A—conduct disorder	4.03e-05	0.000316	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CGA—conduct disorder	4e-05	0.000313	CbGpPWpGaD
Bromocriptine—ADRA1D—GPCR downstream signaling—HTR2A—conduct disorder	3.97e-05	0.000311	CbGpPWpGaD
Bromocriptine—DRD3—GPCR downstream signaling—HTR2A—conduct disorder	3.97e-05	0.000311	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—WASF1—conduct disorder	3.94e-05	0.000309	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—WASF1—conduct disorder	3.88e-05	0.000304	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling by GPCR—HTR2A—conduct disorder	3.88e-05	0.000304	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—DRD4—conduct disorder	3.85e-05	0.000301	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—DRD4—conduct disorder	3.84e-05	0.000301	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—DRD4—conduct disorder	3.82e-05	0.000299	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—DRD4—conduct disorder	3.79e-05	0.000297	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—DRD4—conduct disorder	3.74e-05	0.000293	CbGpPWpGaD
Bromocriptine—DRD1—Signaling by GPCR—HTR2A—conduct disorder	3.66e-05	0.000287	CbGpPWpGaD
Bromocriptine—ADRB1—GPCR downstream signaling—HTR2A—conduct disorder	3.62e-05	0.000284	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling by GPCR—HTR2A—conduct disorder	3.61e-05	0.000283	CbGpPWpGaD
Bromocriptine—DRD3—Signaling by GPCR—HTR2A—conduct disorder	3.61e-05	0.000283	CbGpPWpGaD
Bromocriptine—ADRA2B—GPCR downstream signaling—HTR2A—conduct disorder	3.59e-05	0.000281	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—WASF1—conduct disorder	3.58e-05	0.00028	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—WASF1—conduct disorder	3.52e-05	0.000276	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—DRD4—conduct disorder	3.51e-05	0.000275	CbGpPWpGaD
Bromocriptine—HTR1A—GPCR downstream signaling—HTR2A—conduct disorder	3.46e-05	0.000271	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—WASF1—conduct disorder	3.45e-05	0.00027	CbGpPWpGaD
Bromocriptine—HTR2C—GPCR downstream signaling—HTR2A—conduct disorder	3.44e-05	0.00027	CbGpPWpGaD
Bromocriptine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	3.44e-05	0.00027	CbGpPWpGaD
Bromocriptine—ADRA2C—GPCR downstream signaling—HTR2A—conduct disorder	3.35e-05	0.000263	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—DRD4—conduct disorder	3.31e-05	0.000259	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—CGA—conduct disorder	3.3e-05	0.000259	CbGpPWpGaD
Bromocriptine—ADRA1B—GPCR downstream signaling—HTR2A—conduct disorder	3.3e-05	0.000258	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—HTR2A—conduct disorder	3.29e-05	0.000258	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—DRD4—conduct disorder	3.27e-05	0.000256	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—DRD4—conduct disorder	3.27e-05	0.000256	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—HTR2A—conduct disorder	3.26e-05	0.000255	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—HTR2A—conduct disorder	3.25e-05	0.000255	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—WASF1—conduct disorder	3.2e-05	0.000251	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—HTR2A—conduct disorder	3.14e-05	0.000246	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—HTR2A—conduct disorder	3.13e-05	0.000245	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—HTR2A—conduct disorder	3.04e-05	0.000238	CbGpPWpGaD
Bromocriptine—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	3.04e-05	0.000238	CbGpPWpGaD
Bromocriptine—ADRA2B—Hemostasis—EP300—conduct disorder	3.01e-05	0.000236	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—HTR2A—conduct disorder	2.99e-05	0.000235	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—DRD4—conduct disorder	2.98e-05	0.000233	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—DRD4—conduct disorder	2.95e-05	0.000231	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—HTR2A—conduct disorder	2.93e-05	0.00023	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—DRD4—conduct disorder	2.85e-05	0.000223	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—DRD4—conduct disorder	2.83e-05	0.000222	CbGpPWpGaD
Bromocriptine—ADRA2C—Hemostasis—EP300—conduct disorder	2.81e-05	0.00022	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—HTR2A—conduct disorder	2.76e-05	0.000216	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—DRD4—conduct disorder	2.75e-05	0.000216	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—HTR2A—conduct disorder	2.72e-05	0.000213	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—DRD4—conduct disorder	2.71e-05	0.000212	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—HTR2A—conduct disorder	2.66e-05	0.000208	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—COMT—conduct disorder	2.66e-05	0.000208	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—CGA—conduct disorder	2.64e-05	0.000207	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—MAOA—conduct disorder	2.64e-05	0.000207	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—HTR2A—conduct disorder	2.51e-05	0.000197	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—HTR2A—conduct disorder	2.51e-05	0.000196	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—DRD4—conduct disorder	2.5e-05	0.000196	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—HTR2A—conduct disorder	2.49e-05	0.000195	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—HTR2A—conduct disorder	2.47e-05	0.000194	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—DRD4—conduct disorder	2.46e-05	0.000193	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—HTR2A—conduct disorder	2.44e-05	0.000191	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—DRD4—conduct disorder	2.41e-05	0.000189	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—HTR2A—conduct disorder	2.4e-05	0.000188	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—HTR2A—conduct disorder	2.29e-05	0.000179	CbGpPWpGaD
Bromocriptine—ADRA2A—Hemostasis—EP300—conduct disorder	2.28e-05	0.000179	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—DRD4—conduct disorder	2.24e-05	0.000175	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—HTR2A—conduct disorder	2.16e-05	0.000169	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—COMT—conduct disorder	2.16e-05	0.000169	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—MAOA—conduct disorder	2.14e-05	0.000168	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—HTR2A—conduct disorder	2.13e-05	0.000167	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—HTR2A—conduct disorder	2.13e-05	0.000167	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—CGA—conduct disorder	2.04e-05	0.00016	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—HTR2A—conduct disorder	1.94e-05	0.000152	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—HTR2A—conduct disorder	1.92e-05	0.000151	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—HTR2A—conduct disorder	1.86e-05	0.000146	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—HTR2A—conduct disorder	1.85e-05	0.000145	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—HTR2A—conduct disorder	1.8e-05	0.000141	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—HTR2A—conduct disorder	1.77e-05	0.000139	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—EP300—conduct disorder	1.72e-05	0.000135	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—HTR2A—conduct disorder	1.63e-05	0.000128	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—HTR2A—conduct disorder	1.57e-05	0.000123	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—COMT—conduct disorder	1.49e-05	0.000117	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—MAOA—conduct disorder	1.48e-05	0.000116	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—HTR2A—conduct disorder	1.46e-05	0.000114	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—EP300—conduct disorder	1.33e-05	0.000104	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—EP300—conduct disorder	1.33e-05	0.000104	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—EP300—conduct disorder	1.32e-05	0.000103	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—EP300—conduct disorder	1.29e-05	0.000101	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—EP300—conduct disorder	1.27e-05	9.96e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—EP300—conduct disorder	1.21e-05	9.51e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—COMT—conduct disorder	1.19e-05	9.33e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—MAOA—conduct disorder	1.18e-05	9.27e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.15e-05	8.98e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—EP300—conduct disorder	1.14e-05	8.97e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—EP300—conduct disorder	1.14e-05	8.92e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—EP300—conduct disorder	1.13e-05	8.85e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—EP300—conduct disorder	1.13e-05	8.85e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—EP300—conduct disorder	1.03e-05	8.06e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—EP300—conduct disorder	1.02e-05	7.99e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—EP300—conduct disorder	9.84e-06	7.71e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—EP300—conduct disorder	9.79e-06	7.67e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—EP300—conduct disorder	9.52e-06	7.46e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—EP300—conduct disorder	9.37e-06	7.34e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—EP300—conduct disorder	9.25e-06	7.25e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—COMT—conduct disorder	9.19e-06	7.2e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—MAOA—conduct disorder	9.12e-06	7.15e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—EP300—conduct disorder	8.64e-06	6.77e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—EP300—conduct disorder	8.5e-06	6.66e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—EP300—conduct disorder	8.32e-06	6.52e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—EP300—conduct disorder	7.73e-06	6.06e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—EP300—conduct disorder	6.4e-06	5.01e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—EP300—conduct disorder	5.11e-06	4e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—EP300—conduct disorder	3.94e-06	3.09e-05	CbGpPWpGaD
